TP53 and breast carcinoma: In addition, distinct biological features of Asian breast cancer include higher prevalence of luminal B subtype, more frequent TP53 mutation, and more active immune microenvironment, suggesting the needs for inclusion of more Asian women in clinical trials to unravel the ethnic difference of breast cancer (21, 22).